Koyfin Home > Directory > Health Care > Kindred Biosciences > Net Debt / EBITDA

Kindred Biosciences Net Debt / EBITDA Chart (KIN)

Kindred Biosciences annual/quarterly Net Debt / EBITDA from 2013 to 2020. Net Debt / EBITDA is a measure of leverage for a company by dividing the Debt less Cash on hand vs. EBITDA.
  • Kindred Biosciences Net Debt / EBITDA for the quarter ending June 06, 2020 was $1m a -8.13% decrease of 0m year over year
  • Kindred Biosciences Net Debt / EBITDA for the last 12 months ending June 06, 2020 was $1m a -49.40% decrease of 0m year over year
  • Kindred Biosciences Annual Net Debt / EBITDA for 2019 was $1m a -77.22% decrease of -1m from 2018
  • Kindred Biosciences Annual Net Debt / EBITDA for 2018 was $1m a -77.33% decrease of -1m from 2017
  • Kindred Biosciences Annual Net Debt / EBITDA for 2017 was $3m a 0.79% increase of 0m from 2016
Other Ratios Metrics:
  • Kindred Biosciences Other Liabilities for the quarter ending December 12, 2018 was $0m a -18.09% decrease of 0m year over year
View Chart On Koyfin

Quarterly KIN Net Debt / EBITDA Data

06/2020$1m
03/2020$0m
12/2019$1m
09/2019$1m
06/2019$1m
03/2019$1m
12/2018$1m
09/2018$2m
06/2018$2m
03/2018$2m

Annual KIN Net Debt / EBITDA Data

2019$1m
2018$1m
2017$3m
2016$3m
2015$3m
2014$4m
2013$15m